List view / Grid view
21 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
Research suggest that the use of smart pills should be only after carefully evaluating their clinical efficacy against standard of care drugs...
18 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
Researchers have developed a blood test to detect pancreatic cancer at its earliest stages with an accuracy rate of 96 percent...
14 September 2018 | By Mike Stones
The inhaled version of a high blood pressure drug may treat some types of anxiety and pain, reveals new research from the Centre for Addiction and Mental Health...
14 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
Researchers from the University of Oxford have identified that only 49.5 percent of clinical trials correctly report their results on time...
13 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
A sugar pill could benefit patients suffering from chronic pain with specific brain anatomy and psychological traits...
6 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
The US FDA have granted the NDA for iclaprim, an antibiotic for a skin condition, Priority Review, with a decision date set for February 2019...
5 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
The NHS has announced a groundbreaking new treatment, CAR-T, for children with leukaemia...
4 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
The US FDA is looking to begin a new phase of innovative clinical trial designs...
3 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
In a recent clinical study, ibudilast slowed brain shrinkage better than a placebo in the brains of patients with multiple sclerosis...
31 August 2018 | By Mike Stones
This is the first study to show the clinical benefit of FFRCT in patients with moderate stenosis, said Dr Bjarne Linde Norgaard of Aarhus University Hospital...
30 August 2018 | By Mike Stones
“Our finding of reduced aortic dilatation with irbesartan, over and above standard medical therapy, suggests an important clinical effect that may prevent complications and ultimately delay or obviate the need for surgical intervention in patients with Marfan syndrome,” said Dr Mullen.
23 August 2018 | By Iqra Farooq (European Pharmaceutical Review)
The FDA has approved the first treatment for neurotrophic keratitis, which completely healed the rare disease in 70 percent of cases.
21 August 2018 | By Iqra Farooq (European Pharmaceutical Review)
The study focused on children and young adults receiving proton radiotherapy for brain tumours...
15 August 2018 | By European Pharmaceutical Review
Patients were randomly assigned to be given ordinary care by their doctor, or the Triple Pill, a combination of three blood pressure drugs at lower doses...
14 August 2018 | By European Pharmaceutical Review
"Previous studies have found an alarming rise in ACOS in women in recent years and that the mortality rate from ACOS was higher in women," said Prof To...
Follow: